from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3563/fadE32

LFCtreatmentdescriptionclass of inhibitor

-0.037

Amikacinug/mL Amikacintranslation

-0.677

Cap5-10ug/mL Capreomycintranslation

-0.583

Rox10-50 ug/mL Roxithromycintranslation

-0.712

SM2-5 ug/mL Streptomycintranslation

0.100

Tet5-10 ug/mL Tetracyclinetranslation

0.620

Rif0.2-5ug/mL Rifampicintranscription

0.242

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.995

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.088

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.451

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.381

Clofazimine10-13 ug/mL Clofaziminerespiration

0.050

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.439

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.839

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

1.127

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.365

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.233

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.183

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.758

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.638

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.737

KCN5-20 ug/mL Potassium cyaniderespiration

0.603

NaN30.2-2 mM Sodium aziderespiration

0.370

Nigericin50 uM Nigericinrespiration

0.033

TRC10-150 ug/mL Triclosanrespiration

0.118

TRZ10-25 ug/mL Thioridazinerespiration

1.119

Valinomycin0.5-10 uM Valinomycinrespiration

-0.344

ZnSO42 mM ZnSO4respiration

-0.966

menadione6-10 ug/mL Menadionerespiration

0.618

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.714

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.223

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.044

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.081

NRP_1Non-replicating persistence stage 1dosRassociated

-1.071

Amp0.2mg/mL AmpicillincellWall

-0.539

Cephalexin20-100 ug/mL CephalexincellWall

-0.590

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.750

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.711

EMB10-20 ug/mL EthambutolcellWall

-0.642

Eta12-40 ug/mL EthionamidecellWall

-0.580

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.302

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.064

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.711

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.927

BZA0.12 mg/mL BenzamidearomaticAmides

0.296

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.711

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.287

H2O24 mM hydrogen peroxideDNAdamaging

-0.219

Levo10 ug/mL LevofloxacinDNAdamaging

-0.484

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.851

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.037

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.189

UVUV-irradiationDNAdamaging

0.389

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.469

Antimycin12.5-50 ug/mL Antimycin A?

-0.092

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.670

PA_110-50 ug/mL Antitubercular compound PA-1?

-1.126

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.621

PA8240.2-2 ug/mL PA-824?

1.250

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.031

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.182

Verapamil50 uM Verapamil?

0.655

mercaptoethanol2 mM 2-Mercaptoethanol?

0.203

methoxatin10-20 ug/mL Methoxatin?